Advertisement
Research Article

Dendritic Cell Based PSMA Immunotherapy for Prostate Cancer Using a CD40-Targeted Adenovirus Vector

  • Briana Jill Williams,

    Affiliation: Gene Therapy Program, Departments of Urology, Biochemistry and Molecular Biology, and Cellular Biology and Anatomy, and the Feist-Weiller Cancer Center, LSU Health Sciences Center, Shreveport, Louisiana, United States of America

    X
  • Shilpa Bhatia,

    Affiliation: Gene Therapy Program, Departments of Urology, Biochemistry and Molecular Biology, and Cellular Biology and Anatomy, and the Feist-Weiller Cancer Center, LSU Health Sciences Center, Shreveport, Louisiana, United States of America

    X
  • Lisa K. Adams,

    Affiliation: Gene Therapy Program, Departments of Urology, Biochemistry and Molecular Biology, and Cellular Biology and Anatomy, and the Feist-Weiller Cancer Center, LSU Health Sciences Center, Shreveport, Louisiana, United States of America

    X
  • Susan Boling,

    Affiliation: Gene Therapy Program, Departments of Urology, Biochemistry and Molecular Biology, and Cellular Biology and Anatomy, and the Feist-Weiller Cancer Center, LSU Health Sciences Center, Shreveport, Louisiana, United States of America

    X
  • Jennifer L. Carroll,

    Affiliation: Gene Therapy Program, Departments of Urology, Biochemistry and Molecular Biology, and Cellular Biology and Anatomy, and the Feist-Weiller Cancer Center, LSU Health Sciences Center, Shreveport, Louisiana, United States of America

    X
  • Xiao-Lin Li,

    Affiliation: Gene Therapy Program, Departments of Urology, Biochemistry and Molecular Biology, and Cellular Biology and Anatomy, and the Feist-Weiller Cancer Center, LSU Health Sciences Center, Shreveport, Louisiana, United States of America

    X
  • Donna L. Rogers,

    Affiliation: Gene Therapy Program, Departments of Urology, Biochemistry and Molecular Biology, and Cellular Biology and Anatomy, and the Feist-Weiller Cancer Center, LSU Health Sciences Center, Shreveport, Louisiana, United States of America

    X
  • Nikolay Korokhov,

    Affiliation: VectorLogics, Inc., Birmingham, Alabama, United States of America

    X
  • Imre Kovesdi,

    Affiliation: VectorLogics, Inc., Birmingham, Alabama, United States of America

    X
  • Alexander V. Pereboev,

    Affiliation: Departments of Medicine and Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

    X
  • David T. Curiel,

    Affiliation: Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • J. Michael Mathis mail

    jmathi@lsuhsc.edu

    Affiliation: Gene Therapy Program, Departments of Urology, Biochemistry and Molecular Biology, and Cellular Biology and Anatomy, and the Feist-Weiller Cancer Center, LSU Health Sciences Center, Shreveport, Louisiana, United States of America

    X
  • Published: October 08, 2012
  • DOI: 10.1371/journal.pone.0046981

Reader Comments (0)

Post a new comment on this article